Issue Date: April 17, 2017
Frequency Therapeutics launches to tackle hearing loss
Frequency Therapeutics, started in 2015 with the lofty goal of reversing damage that causes hearing loss, has raised $32 million in its first major round of financing. The Waltham, Mass.-based firm is founded on technology emerging from the labs of MIT chemical engineer Robert Langer and Harvard Medical School biomedical engineer Jeffrey Karp.
Frequency hopes to reverse hearing loss by regenerating lost hair cells, the tuftlike projections that line the inner ear and are critical . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society